<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Osivax Creates Universal Influenza and Coronavirus Vaccine
Image Overlay - Osivax Creates Universal Influenza and Coronavirus Vaccine

Osivax Creates Universal Influenza and Coronavirus Vaccine

July 16, 2020

Osivax Creates Universal Influenza and Coronavirus Vaccine

French biotech Osivax was granted 30 million euros in public funding for the development of a universal vaccine against both influenza and coronavirus. With 21 GMP certified depots located around the world, including Europe, Yourway provides all customers with quality assurance and is focused on regulatory compliance--this is crucial when testing a vaccine around the world.

Back to Index
Media

Upcoming Events

Global Clinical Trial Innovation, Challenges, and Perspectives

June 6, 2024
Yourway's EU Flagship Depot in Dublin, Ireland

Precision in Pharma Supply Chain & Logistics Summit (San Diego)

October 21-22, 2024
San Diego

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?